Atrogi’s oral candidate mimics exercise to pre
Author: Michael
Khosla-backed company aims to double number of l
Buck Institute study reveals how sugar breakdown
Licensing agreement with Chinese biotech Mabwell
NFX General Partner Omri Drory discusses why lon
Immortal Dragons founder explains how a purpose-
Clinical stage ‘mitochondrial augmentation’
New analyses reveal widespread discrepancies in
Real-world data suggest GLP-1 drugs like Ozempic
Researchers propose protocol for standardizing l